Scott Kellen - 28 Jul 2021 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
CFO and Secretary
Signature
/s/ Amy Culbert, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
28 Jul 2021
Net transactions value
$0
Form type
4
Filing time
29 Jul 2021, 21:02:54 UTC
Next filing
16 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DMAC Voting Common Shares, no par value per share 12,290 28 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAC Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 28 Jul 2021 Common Shares 60,000 $5.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in sixteen nearly equal quarterly installments over four years.